Live Chat

Trade AbbVie ABBV

AbbVie live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
date Close change Change (%) Open High Low

News

Info

Spread

1.16

Spread (%)

0.6162 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

359538491392

Shares Outstanding

1766339968

Earnings Date (Next)

0000-00-00

instr__dividend_date

2024-11-15

instr__ex_dividend_date

2025-01-15

instr__forward_annual_dividend_rate

6.56

instr__forward_annual_dividend_yield

0.0322

EPS

2.87

Learn more about this instrument

AbbVie AbbVie Inc
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest news

Stay updated with the latest financial news from around the world.

Thursday, 31 October 2024

Intel stock price jumps 7% on positive outlook despite Q3 losses

Thursday, 31 October 2024

Crypto market surges: Bitcoin ETF inflows reached $870 million

US Election 2024, Harris vs Trump

Thursday, 31 October 2024

Week ahead: Trump vs Harris US Election Showdown

Bank of England and Union Jack flag

Thursday, 31 October 2024

UK Budget Fallout: Economic Growth, Debt, and Market Reactions

Thursday, 31 October 2024

Roblox Q3 earnings increased with 34%, Roblox (RBLX) Stock Surges 20%

Thursday, 31 October 2024

China Market Update: BYD overtakes Tesla earnings for the first time

Thursday, 31 October 2024

AMZN share price: Amazon stock jumps after Q3 earnings beat

UK markets react to budget

Thursday, 31 October 2024

UK Markets React to Budget with Sterling and Gilt Decline

Trustpilot
Live Chat